 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 10/13/2017 |
$17.65 |
$17.89 |
$15.75 |
$16.10 |
1.98M | | 10/16/2017 |
$17.10 |
$17.30 |
$16.00 |
$16.70 |
1.25M | | 10/17/2017 |
$17.40 |
$18.35 |
$16.55 |
$17.90 |
3.91M | | 10/18/2017 |
$17.75 |
$18.00 |
$16.70 |
$17.50 |
1.86M | | 10/19/2017 |
$17.35 |
$17.90 |
$17.20 |
$17.75 |
1.05M |
|
|
| Abeona Therapeutics is a clinical stage biopharmaceutical company developing gene therapies for life-threatening rare genetic diseases. Co.'s primary programs are ABO-102 and ABO-101, adeno-associated virus based gene therapies for Sanfilippo syndrome. Co. also develops EB-101, gene-corrected skin grafts for recessive dystrophic epidermolysis bullosa; EB-201 for epidermolysis bullosa; ABO-201, gene therapy for juvenile Batten disease; ABO-202 gene therapy for treatment of infantile Batten disease; ABO-301 for Fanconi anemia disorder; and ABO-302 for rare blood diseases. Co. has a plasma-based protein therapy platform, using its proprietary SDFTM (Salt Diafiltration) ethanol-free process. |
|
|
Abeona Therapeutics (ABEO) has the following price history information. Looking back at ABEO historical stock prices for the last five trading days, on October 13, 2017, ABEO opened at $17.65, traded as high as $17.89 and as low as $15.75, and closed at $16.10. Trading volume was a total of 1.98M shares. On October 16, 2017, ABEO opened at $17.10, traded as high as $17.30 and as low as $16.00, and closed at $16.70. Trading volume was a total of 1.25M shares. On October 17, 2017, ABEO opened at $17.40, traded as high as $18.35 and as low as $16.55, and closed at $17.90. Trading volume was a total of 3.91M shares. On October 18, 2017, ABEO opened at $17.75, traded as high as $18.00 and as low as $16.70, and closed at $17.50. Trading volume was a total of 1.86M shares. On October 19, 2017, ABEO opened at $17.35, traded as high as $17.90 and as low as $17.20, and closed at $17.75. Trading volume was a total of 1.05M shares.
ABEO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Abeona Therapeutics shares, starting with a $10,000 purchase of ABEO, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
10/22/2007 |
|
| End date: |
10/19/2017 |
|
| Start price/share: |
$3.90 |
|
| End price/share: |
$17.75 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
355.13% |
|
| Average Annual Total Return: |
16.36% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$45,502.70 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 10/13/2017 | $16.10 | | 10/16/2017 | $16.70 | | 10/17/2017 | $17.90 | | 10/18/2017 | $17.50 | | 10/19/2017 | $17.75 |
|
|
